Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-03

Clinical Trial Update: (Hyoscine Butylbromide) for Abdominal Pain Associated With Cramping on Demand Basis [Phase 2]

View source ↗

Summary

Phase 2 trial update for hyoscine butylbromide evaluating on-demand treatment for abdominal pain with cramping; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyoscine Butylbromide (hyoscine butylbromide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Abdominal Pain | Phase 2 | Status: COMPLETED | Results posted: 2022-05-03